Wednesday, November 19, 2014

Dr. Reddy gets USFDA Approval to market copies of OTC Allegra D

The USFDA has granted approval to Dr.Reddy for marketing OTC and generic version of combination pill -fexofenadine hydrochloride - pseudoephedrine hydrochloride (Allegra - D 12 hrs). Allegra-D 12 Hour is nasal decongestant and is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older.
For the 9 month ending September 2014, Allegra family had annual sales of approximately $150million

Enter your email address:


Delivered by FeedBurner